Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph phase_3
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Active, not recruiting1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 33 (100.0%)

Trials by Status

active_not_recruiting133%
not_yet_recruiting133%
recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
not_yet_recruitingphase_3

Pivotal Study of N-acetyl-L-leucine for CACNA1A

NCT07221292
active_not_recruitingphase_3

A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)

NCT06673056
recruitingphase_3

A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C

NCT05163288

Clinical Trials (3)

Showing 3 of 3 trials
NCT07221292Phase 3

Pivotal Study of N-acetyl-L-leucine for CACNA1A

Not Yet Recruiting
NCT06673056Phase 3

A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)

Active Not Recruiting
NCT05163288Phase 3

A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3